Rating History for 9 Meter Biopharma (NMTR) by Brookline Capital Markets

More Stocks Rated by Brookline Capital Markets | Latest Ratings for NMTR
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
5/26/2023 Kemp Dolliver Downgrade Hold
(Buy)		 N/A
(N/A)		 0.78
(0.07)		 -91.03% Details